Amisulpride to prevent nausea after gynecological laparoscopic surgery
Part of Digestive system clinical trials.
This trial tests whether a medication called amisulpride can reduce nausea and vomiting after gynecological surgery (surgery on the ovaries, fallopian tubes, or uterus using small incisions). Many patients feel sick after surgery, and this study aims to find out if this drug helps prevent that.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a BMI (body mass index) between 18 and 30 kg/m²
- You are scheduled for gynecological laparoscopic surgery (ovary, fallopian tube, or uterus surgery with small incisions) expected to last 3 hours or less
- You are not pregnant or breastfeeding
- You have not taken anti-nausea medications in the past 7 days
- You do not have a history of balance problems, chronic dizziness, or serious nausea issues
- You do not have neurological, psychiatric, or cognitive disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether TEAS (a noninvasive electrical stimulation you receive during surgery) can reduce nausea and vomiting after spinal surgery. You might benefit if you’re at risk of “PONV” (post-surgery nausea and vomiting) and can safely take part in an acupoint-based stimulation study.
This trial tests if adding a medication called amisulpride to standard anti-nausea drugs can better prevent vomiting and nausea after gynecologic surgery. It is for women at high risk of postoperative nausea.
This trial tests a combination of methods to prevent nausea and vomiting after gynecological surgery using a laparoscope (a small camera). The study uses acupressure and other supportive care techniques to see if they can reduce post-surgery nausea, which is a common and uncomfortable side effect.
This trial tests a combination of three medicines given during surgery to reduce nausea and vomiting after anesthesia. You might be eligible if you’re having laparoscopic gynecologic surgery and meet the age and health requirements.
This trial tests if adding HRS5580 to standard anti-nausea medicine works better to stop vomiting after surgery. You may qualify if you are at moderate-to-high risk for nausea after general anesthesia.
This trial tests an aprepitant injection to prevent nausea and vomiting after laparoscopic gynecologic or abdominal surgery lasting at least 1 hour. It may be an option for people who want to reduce post-operative sickness.
Hear when a new PONV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.